ApostolosA, DrakopoulouM, GregoriouS, et al.Nickel hypersensitivity to atrial septal occluders: Smoke without fire? Clin Rev Allergy Immunol., 2022; 62(3):476–483.
2.
ApostolosA, GregoriouS, DrakopoulouM, et al.Patent foramen ovale closure in patients with and without nickel hypersensitivity: A randomized trial. Circ Cardiovasc Interv., 2025; 18(4):e015228.
3.
ApostolosA, GregoriouS, DrakopoulouM, et al.Sex-specific differences in patients with and without nickel hypersensitivity undergoing patent foramen ovale closure. JACC Adv., 2025; 4(10 Pt 2):102186.
4.
RiesMW, KampmannC, RupprechtH-J, et al.Nickel release after implantation of the amplatzer occluder. Am Heart J., 2003; 145(4):737–741.
5.
UterW, WilkinsonSM, AertsO, et al.; ESSCA and EBS ESCD working groups, and the GEIDAC. Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC. Contact Dermatitis., 2022; 87(4):343–355.